Tuberculosis Trials Consortium Study 31

2018-02-05T16:32:49Z (GMT) by Payam Nahid
Tuberculosis Trials Consortium Study 31
Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial - Payam Nahid

This presentation was delivered at the 2017 INTERTB symposium, held at St George’s, University of London. The full collection of outputs from the meeting are available from the link below.